Vaccines exist to prevent Ebola, but there is no approved vaccine or drug treatment for the Sudan strain of the virus, which caused the recent outbreak in Uganda. A clinical trial of three vaccines — made by the Washington-based Sabin Vaccine Institute, the University of Oxford and the American pharmaceutical company Merck — is being prepared. Researchers have also begun a clinical trial of two monoclonal antibodies donated by the United States that can help boost patients’ chances of survival. […]
Read More… from ‘Ebola Could Have Wiped Us All’: Slow Lockdown Haunts Uganda